Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125195282 | 12519528 | 2 | F | 20060220 | 20160811 | 20160630 | 20160819 | EXP | US-ASTRAZENECA-2009BM14481 | ASTRAZENECA | 52.00 | YR | M | Y | 95.30000 | KG | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125195282 | 12519528 | 1 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | FL0209 | 0 | 2 | MG | /wk | |||||||
| 125195282 | 12519528 | 2 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | A594550A | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 125195282 | 12519528 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 125195282 | 12519528 | 4 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 125195282 | 12519528 | 5 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 2500 | MG | QD | ||||||||
| 125195282 | 12519528 | 6 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 0 | 4 | MG | QD | ||||||||
| 125195282 | 12519528 | 7 | C | AVANDIA | ROSIGLITAZONE MALEATE | 1 | 0 | ||||||||||||
| 125195282 | 12519528 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125195282 | 12519528 | 9 | C | PRANDIN | REPAGLINIDE | 1 | 0 | ||||||||||||
| 125195282 | 12519528 | 10 | C | VICTOZA | LIRAGLUTIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125195282 | 12519528 | 1 | Type 2 diabetes mellitus |
| 125195282 | 12519528 | 2 | Type 2 diabetes mellitus |
| 125195282 | 12519528 | 3 | Type 2 diabetes mellitus |
| 125195282 | 12519528 | 4 | Type 2 diabetes mellitus |
| 125195282 | 12519528 | 5 | Type 2 diabetes mellitus |
| 125195282 | 12519528 | 6 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125195282 | 12519528 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125195282 | 12519528 | Back disorder | |
| 125195282 | 12519528 | Blood glucose decreased | |
| 125195282 | 12519528 | Blood glucose increased | |
| 125195282 | 12519528 | Device malfunction | |
| 125195282 | 12519528 | Drug effect decreased | |
| 125195282 | 12519528 | Drug effect incomplete | |
| 125195282 | 12519528 | Injection site pain | |
| 125195282 | 12519528 | Nausea | |
| 125195282 | 12519528 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125195282 | 12519528 | 2 | 200603 | 20091226 | 0 | |
| 125195282 | 12519528 | 3 | 20060220 | 200603 | 0 | |
| 125195282 | 12519528 | 4 | 20091227 | 0 |